Growth factors in benign prostatic hyperplasia: basic science implications (Q37258877)

19 August 2017

1 reference

title

Growth factors in benign prostatic hyperplasia: basic science implications (English)

1 reference

19 August 2017

main subject

prostatic hypertrophy

1 reference

M Scott Lucia

1

1 reference

19 August 2017

James R Lambert

series ordinal

2

1 reference

19 August 2017

publication date

1 July 2008

1 reference

19 August 2017

published in

Current urology reports

1 reference

19 August 2017

volume

9

1 reference

19 August 2017

issue

4

1 reference

19 August 2017

page(s)

272-278

1 reference

Expression and function of pro-inflammatory interleukin IL-17 and IL-17 receptor in normal, benign hyperplastic, and malignant prostate.

19 August 2017

cites work

1 reference

12 December 2020

Decreased expression of Wilms' tumor gene WT-1 and elevated expression of insulin growth factor-II (IGF-II) and type 1 IGF receptor genes in prostatic stromal cells from patients with benign prostatic hyperplasia

1 reference

12 December 2020

The int-2 gene product acts as an epithelial growth factor in transgenic mice

1 reference

12 December 2020

Molecular and cellular pathogenesis of benign prostatic hyperplasia

1 reference

12 December 2020

Prostatic involution in men taking finasteride is associated with elevated levels of insulin-like growth factor-binding proteins (IGFBPs)-2, -4, and -5

1 reference

12 December 2020

Increased expression of CYR61, an extracellular matrix signaling protein, in human benign prostatic hyperplasia and its regulation by lysophosphatidic acid

1 reference

12 December 2020

Gene expression signature of benign prostatic hyperplasia revealed by cDNA microarray analysis

1 reference

12 December 2020

Increased expression of lymphocyte-derived cytokines in benign hyperplastic prostate tissue, identification of the producing cell types, and effect of differentially expressed cytokines on stromal cell proliferation

1 reference

12 December 2020

Interleukin-8 expression is increased in senescent prostatic epithelial cells and promotes the development of benign prostatic hyperplasia

1 reference

12 December 2020

Seminal plasma cytokines and chemokines in prostate inflammation: interleukin 8 as a predictive biomarker in chronic prostatitis/chronic pelvic pain syndrome and benign prostatic hyperplasia

1 reference

12 December 2020

Expression and cellular localization of keratinocyte growth factor and its receptor in human hyperplastic prostate tissue

1 reference

12 December 2020

Increased expression of genes for basic fibroblast growth factor and transforming growth factor type beta 2 in human benign prostatic hyperplasia

1 reference

12 December 2020

Stimulative effect of transforming growth factor-beta on collagen synthesis by human prostatic stromal cells in vitro

1 reference

12 December 2020

Effect of keratinocyte growth factor on cell viability in primary cultured human prostate cancer stromal cells

1 reference

12 December 2020

Interleukin-8 is a paracrine inducer of fibroblast growth factor 2, a stromal and epithelial growth factor in benign prostatic hyperplasia

1 reference

12 December 2020

Expression of fibroblast growth factors (FGFs) and FGF receptors in human prostate

1 reference

12 December 2020

Transforming growth factor beta 1 and its receptor types I and II. Comparison in human normal prostate, benign prostatic hyperplasia, and prostatic carcinoma

1 reference

12 December 2020

The insulin-like growth factor type I receptor stimulates growth and suppresses apoptosis in prostatic stromal cells

1 reference

12 December 2020

Secretion of insulin-like growth factors and their binding proteins by human normal and hyperplastic prostatic cells in primary culture

1 reference

12 December 2020

Intrinsic and extrinsic factors controlling benign prostatic growth

1 reference

12 December 2020

Phenotype and function of peripheral and prostatic lymphocytes in patients with benign prostatic hyperplasia

1 reference

12 December 2020

Regional variations of insulin-like growth factor I (IGF-I), IGF-II, and receptor type I in benign prostatic hyperplasia tissue and their correlation with intraprostatic androgens

1 reference

12 December 2020

Fibroblast growth factor receptor 1 (FGFR1) is over-expressed in benign prostatic hyperplasia whereas FGFR2-IIIc and FGFR3 are not

1 reference

12 December 2020

Association of prostatic inflammation with down-regulation of macrophage inhibitory cytokine-1 gene in symptomatic benign prostatic hyperplasia

1 reference

12 December 2020

FGF9 is an autocrine and paracrine prostatic growth factor expressed by prostatic stromal cells

1 reference

12 December 2020

The development of human benign prostatic hyperplasia with age

1 reference

12 December 2020

Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling.

1 reference

12 December 2020

Immunolocalization of the keratinocyte growth factor in benign and neoplastic human prostate and its relation to androgen receptor

1 reference

12 December 2020

Alterations in expression of basic fibroblast growth factor (FGF) 2 and its receptor FGFR-1 in human prostate cancer

1 reference

12 December 2020

Insulin-Like Growth Factors (IGFs), IGF Receptors, and IGF-Binding Proteins in Primary Cultures of Prostate Epithelial Cells*

1 reference

12 December 2020

The natural history of benign prostatic hyperplasia: what have we learned in the last decade?

1 reference

12 December 2020

Thrombospondin-1, vascular endothelial growth factor and fibroblast growth factor-2 are key functional regulators of angiogenesis in the prostate

1 reference

12 December 2020

Profiling molecular targets of TGF-beta1 in prostate fibroblast-to-myofibroblast transdifferentiation

1 reference

12 December 2020

FGF7 and FGF2 are increased in benign prostatic hyperplasia and are associated with increased proliferation

1 reference

12 December 2020

Induction of smooth muscle cell phenotype in cultured human prostatic stromal cells

1 reference

12 December 2020

Tumor inflammatory angiogenesis and its chemoprevention

1 reference

12 December 2020

Morphological analogies of fetal prostate stroma and stromal nodules in BPH

1 reference

12 December 2020

Vascular endothelial growth factor (VEGF) expression in prostate cancer and benign prostatic hyperplasia

1 reference

12 December 2020

Expression of basic fibroblast growth factor and its receptors FGFR1 and FGFR2 in human benign prostatic hyperplasia treated with finasteride

1 reference

12 December 2020

Pathology of benign prostatic hyperplasia. Insight into etiology

1 reference

12 December 2020

Analysis of the inflammatory network in benign prostate hyperplasia and prostate cancer

1 reference

12 December 2020

A human prostatic growth factor (hPGF): partial purification and characterization

1 reference

12 December 2020

Symptomatic and asymptomatic benign prostatic hyperplasia: molecular differentiation by using microarrays

1 reference

12 December 2020

Induction and function of CYR61 (CCN1) in prostatic stromal and epithelial cells: CYR61 is required for prostatic cell proliferation

1 reference

12 December 2020

Asymptomatic inflammation and/or infection in benign prostatic hyperplasia

1 reference

12 December 2020

Down-regulation of macrophage inhibitory cytokine-1/prostate derived factor in benign prostatic hyperplasia

1 reference

12 December 2020

Insulin-like growth factor axis abnormalities in prostatic stromal cells from patients with benign prostatic hyperplasia

1 reference

12 December 2020

Regulation of prostatic stromal cell growth and function by transforming growth factor beta (TGFbeta).

1 reference

12 December 2020

Expression analysis of peptide growth factors VEGF, FGF2, TGFB1, EGF and IGF1 in prostate cancer and benign prostatic hyperplasia.

1 reference

12 December 2020

10.1007/S11934-008-0048-6

Identifiers

DOI

1 reference

19 August 2017

1 reference